[1] The Diabetes Control and Complications Trial Research
Group, The effect of intensive treatment of diabetes on the
development and progression of longer complications in
insulin-dependent diabetes mellitus, N. Engl. J. Med. 329
(1993) 977–986.
[2] UK Prospective Diabetes Study (UKPDS) Group, Intensive
blood-glucose control with sulphonylureas or insulin
compared with conventional treatment and risk of
complications in patients with type 2 diabetes, Lancet 352
(1998) 837–853.
[3] C. Stettler, S. Allemann, P. Ju¨ ni, C.A. Cull, R.R. Holman, M.
Egger, et al., Glycemic control and macrovascular disease in
types 1 and 2 diabetes mellitus: meta-analysis of
randomized trials, Am. Heart J. 152 (2006) 127–138.
[4] I.M. Stratton, A.I. Adler, H.A. Neil, D.R. Matthews, S.E.
Manley, C.A. Cull, et al., Association of glycaemia with
macrovascular and microvascular complications of type 2
diabetes (UKPDS 35): prospective observational study, BMJ
321 (2000) 405–412.
[5] K.T. Khaw, N. Wareham, R. Luben, S. Bingham, S. Oakes, A.
Welch, et al., Glycated haemoglobin, diabetes, and
mortality in men in Norfolk cohort of european prospective
investigation of cancer and nutrition (EPIC-Norfolk), BMJ
322 (2001) 15–18.
[6] H.C. Gerstein, et al., The relationship between
dysglycaemia and cardiovascular and renal risk in diabetic
and non-diabetic participants in the HOPE study: a
prospective epidemiological analysis, Diabetologia 48 (2005)
1749–1755.
[7] P.B. Mellen, V. Bittner, D.M. Herrington, Post-challenge
glucose predicts coronary atherosclerotic progression in
non-diabetic, post-menopausal women, Diabet. Med. 24
(2007) 1156–1159.
[8] The DECODE Study Group, Glucose tolerance and mortality:
comparison of WHO and American Diabetes Association
diagnostic criteria, Lancet 354 (1999) 617–621.
[9] B. Balkau, M. Shipley, R.J. Jarrett, K. Pyo¨ ra¨ la¨ , M. Pyo¨ ra¨ la¨, A.
Forhan, et al., High blood glucose concentration is a risk
factor for mortality in middle-aged nondiabetic men: 20-
year follow-up in the Whitehall Study, the Paris Prospective
Study, and the Helsinki Policemen Study, Diabetes Care 21
(1998) 360–367.
[10] M. Coutinho, H.C. Gerstein, Y. Wang, S. Yusuf, The
relationship between glucose and incident cardiovascular
events: a metaregression analysis of published data from
20 studies of 95,783 individuals followed for 12.4 years,
Diabetes Care 22 (1999) 233–240.
[11] A. Ceriello, Postprandial hyperglycemia and diabetes
complications: is it time to treat? Diabetes 54 (2005) 1–7.
[12] T.S. Temelkova-Kurktschiev, C. Koehler, E. Henkel, W.
Leonhardt, K. Fuecker, M. Hanefeld, Postchallenge plasma
glucose and glycemic spikes are more strongly associated
with atherosclerosis than fasting glucose or HbA1c level,
Diabetes Care 23 (2000) 1830–1834.
[13] K. Esposito, M. Ciotola, D. Carleo, B. Schisano, L. Sardelli, D.
Di Tommaso, et al., Postmeal glucose peaks at home
associate with carotid intima–media thickness in type 2
diabetes, J. Clin. Endocrinol. Metab. 93 (2008) 1345–1350.
[14] R.J. Esper, R.A. Nordaby, J.O. Vilarin˜ o, A. Paragano, J.L.
Cacharro´ n, R.A. Machado, Endothelial dysfunction: a
comprehensive appraisal, Cardiovasc. Diabetol. 5 (2006) 4.
[15] A. Ceriello, C. Taboga, L. Tonutti, L. Quagliaro, L. Piconi, B.
Bais, et al., Evidence for an independent and cumulative
effect of postprandial hypertriglyceridemia and
hyperglycemia on endothelial dysfunction and oxidative
stress generation: effects of short- and long-term
simvastatin treatment, Circulation 106 (2002) 1211–1218.
[16] M. Brownlee, Biochemistry and molecular cell biology of
diabetic complications, Nature 414 (2001) 813–820.
[17] J.A. Beckman, A.B. Goldfine, M.B. Gordon, M.A. Creager,
Ascorbate restores endothelium-dependent vasodilation
impaired by acute hyperglycemia in humans, Circulation
103 (2001) 1618–1623.
[18] H.H. Ting, F.K. Timimi, K.S. Boles, S.J. Creager, P. Ganz, M.A.
Creager, Vitamin C improves endothelium-dependent
vasodilation in patients with non-insulin-dependent
diabetes mellitus, J. Clin. Invest. 97 (1996) 22–28.
[19] H. Kawano, T. Motoyama, O. Hirashima, N. Hirai, Y. Miyao,
T. Sakamoto, et al., Hyperglycemia rapidly suppresses flowmediated
endothelium-dependent vasodilation of brachial
artery, J. Am. Coll. Cardiol. 34 (1999) 146–154.
[20] S. Del Prato, M. Matsuda, D.C. Simonson, L.C. Groop, P.
Sheehan, F. Leonetti, et al., Studies on the mass action
effect of glucose in NIDDM and IDDM: evidence for glucose
resistance, Diabetologia 40 (1997) 687–697.
[21] A. Ceriello, S. Kumar, L. Piconi, K. Esposito, D. Giugliano,
Simultaneous control of hyperglycemia and oxidative
stress normalizes endothelial function in type 1 diabetes,
Diabetes Care 30 (2007) 649–654.
[22] J.M. Graham, J.A. Higgins, T. Gillott, T. Taylor, J. Wilkinson,
T. Ford, et al., A novel method for the rapid separation of
lipoproteins using self generating gradients of iodixanol,
Atherosclerosis 124 (1996) 124–135.
[23] A. Ceriello, F. Mercuri, L. Quagliaro, R. Assaloni, E. Motz, L.
Tonutti, et al., Detection of nitrotyrosine in the diabetic
plasma: evidence of oxidative stress, Diabetologia 44 (2001)
834–838.
[24] M.C. Corretti, G.D. Plotnick, R.A. Vogel, Technical aspects of
evaluating brachial artery endothelium-dependent
vasodilation using high frequency ultrasound, Am. J.
Physiol. 268 (1995) H1397–H1404.
[25] M.W. Ramsey, J. Goodfellow, C.J. Jones, L.A. Luddington,
M.J. Lewis, A.H. Henderson, Endothelial control of arterial
distensibility is impaired in chronic heart failure,
Circulation 92 (1995) 3212–3219.
[26] C.J. Rodriguez, Y. Miyake, C. Grahame-Clarke, M.R. Di
Tullio, R.R. Sciacca, B. Boden-Albala, et al., Relation of
plasma glucose and endothelial function in a populationbased
multiethnic sample of subjects without diabetes
mellitus, Am. J. Cardiol. 96 (2005) 1273–1277.
[27] A.B. Goldfine, J.A. Beckman, R.A. Betensky, H. Devlin, S.
Hurley, N. Varo, et al., Family history of diabetes is a major
determinant of endothelial function, J. Am. Coll. Cardiol. 47
(2006) 2456–2461.
[28] A. Ceriello, K. Esposito, L. Piconi, M.A. Ihnat, J.E. Thorpe, R.
Testa, et al., Oscillating glucose is more deleterious on
endothelial function and oxidative stress than mean
glucose in normals and type 2 diabetic patients, Diabetes 57
(2008) 1349–1354.
[29] B. Ellger, Y. Debaveye, I. Vanhorebeek, L. Langouche, A.
Giulietti, E. Van Etten, et al., Survival benefits of intensive
insulin therapy in critical illness: impact of maintaining
normoglycemia versus glycemia-independent actions of
insulin, Diabetes 55 (2006) 1096–1105.
[30] R. Marfella, L. Quagliaro, F. Nappo, A. Ceriello, D. Giugliano,
Acute hyperglycemia induces an oxidative stress in healthy
subjects, J. Clin. Invest. 108 (2001) 635–636.
[31] S. Pennathur, J.W. Heinecke, Oxidative stress and
endothelial dysfunction in vascular disease, Curr. Diab.
Rep. 7 (2007) 257–264.
[32] S. Pennathur, J.W. Heinecke, Mechanisms for oxidative
stress in diabetic cardiovascular disease, Antioxid. Redox
Signal 9 (2007) 955–969.
[33] M.H. Shishehbor, R.J. Aviles, M.L. Brennan, X. Fu, M.
Goormastic, G.L. Pearce, et al., Association of nitrotyrosine
levels with cardiovascular disease and modulation by
statin therapy, JAMA 289 (2003) 1675–1680.
[34] A. Ceriello, Acute hyperglycaemia: a ‘new’ risk factor
during myocardial infarction, Eur. Heart J. 26 (2005) 328–
331.
[35] P. Deedwania, et al., Hyperglycemia and acute coronary
syndrome: a scientific statement from the American Heart
Association Diabetes Committee of the Council on
Nutrition, Physical Activity, and Metabolism, Circulation
117 (2008) 1610–1619.